Public company

Abbott Laboratories

As of , Abbott Laboratories is named as a defendant in 36 federal civil dockets observed by Repleader, most in the District Court, N.D. Illinois; its latest reported revenue was $44.328 billion for the fiscal year ended , per its 10-K 0001628280-26-010185.

Data through . Filings on SEC EDGAR. Sources are listed at the end of this page.

Public. Ticker ABT, NYSE. SEC CIK 0000001800.

Repleader rankings and indexes are computed from public records by a published method. They describe litigation and business activity. They are not legal advice, investment advice, or a recommendation to buy, sell or hold any security. A lawsuit is an allegation, not a finding of liability. They are not a recommendation to use or avoid any product.

Dockets naming it
36
Annual revenue
$44.328 billion
Net income
$6.524 billion

Dockets and rankings as of UTC; SEC company facts retrieved .

Facts

Sourced facts about Abbott Laboratories
FactValueSourceDate
Ticker and exchangeABT, NYSEdata.sec.gov
SEC CIK0000001800data.sec.gov
SEC industry code2834 Pharmaceutical Preparationsdata.sec.gov
Latest annual reportForm 10-K for the period ended 2025-12-31sec.gov
Why it is trackedNumerous lawsuits alleging its preterm infant formula caused necrotizing enterocolitis (NEC), per its FY2025 10-K.sec.gov

Identifiers

SEC CIK 0000001800, ticker ABT. Every filing is on the company's EDGAR page.

Annual reports behind the SEC figures on this page, by accession number
Filing and accession numberFiledFiscal years ended
10-K 0001628280-26-010185, ,
10-K 0001628280-25-007110,
10-K 0001628280-24-005348,
10-K 0001628280-23-004026,
10-K 0001104659-22-025141,

Docket numbers of the dockets naming Abbott Laboratories are in the dockets table, each linked to its CourtListener record.

Measured over time

Dockets naming Abbott Laboratories, by month filed

Dockets naming Abbott Laboratories per month filed
Month filedDocketsShare of the busiest month
2
3
4
1
4
3
5
1
5
5
3

Derived numbers

Computed from the records above by a published method, labeled modeled. How they are computed.

Momentum score, rank-1.0

Unranked. Insufficient public data: has revenue growth, scale; missing hiring (no verified public job board); product (no legal AI product line in the universe); voice (headline data pending)

Scorecard: each component's raw input, percentile within the universe and weight
ComponentRaw inputWindowPercentileWeightPoints
Revenue growth$44.328 billion vs $41.95 billion +5.7% modeled latest fiscal year vs prior41.7 modeled35% modeled
Scale$44.328 billion latest fiscal year53.1 modeled15% modeled
Hiringno verified public job boardcounted within the last month20% modeled
Productno legal AI product line in the universecurrent universe15% modeled
Voiceheadline data pendinglast ninety days15% modeled

Litigation exposure, lei-1.0

Observed dockets naming this company as a defendant: 36. The matter index these would be weighted by is not published yet, so the exposure shown is this plain count.

Annual figures reported to the SEC

From SEC EDGAR company facts, annual reports only, as last reported. Each value links to its filing. No stock market data is collected or shown.

XBRL facts by fiscal period end
ConceptLatest filing
Revenue from Contract with Customer, Excluding Assessed Tax
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
$44.328 billion$41.95 billion$40.109 billion$43.653 billion$43.075 billion$34.608 billion10-K
Net Income (Loss) Attributable to Parent
us-gaap:NetIncomeLoss
$6.524 billion$13.402 billion$5.723 billion$6.933 billion$7.071 billion$4.495 billion10-K
Assets
us-gaap:Assets
$86.713 billion$81.414 billion$73.214 billion$74.438 billion$75.196 billion$72.548 billion10-K
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
us-gaap:ProfitLoss
$7.071 billion$4.495 billion10-K
Stockholders' Equity Attributable to Parent
us-gaap:StockholdersEquity
$52.13 billion$47.664 billion$38.603 billion$36.686 billion$35.802 billion$32.784 billion10-K

Litigation reserve

No litigation-specific reserve reported in the SEC data feed for the latest fiscal year. See the annual report. Amounts a company reports under its own tags or by segment are not in this feed, so a blank here does not mean zero.

Dockets naming Abbott Laboratories

Dockets in our records that name this company, newest first
DocketCaseCourtCase typeNamed asFiled
1:26-cv-00213Individual plaintiffDistrict Court, E.D. MissouriHealth Care/Pharmaceutical Personal Injury Product Liabilitydefendant
1:26-cv-10968Individual plaintiffDistrict Court, N.D. IllinoisHealth Care/Pharmaceutical Personal Injury Product Liabilitydefendant
9:26-cv-81076Individual plaintiffDistrict Court, S.D. FloridaHealth Care/Pharmaceutical Personal Injury Product Liabilitydefendant
1:26-cv-10164Individual plaintiffDistrict Court, N.D. IllinoisOther Personal Injurydefendant
1:26-cv-09574Individual plaintiffDistrict Court, N.D. IllinoisPersonal Injury - Product Liabilitydefendant
4:26-cv-03174Individual plaintiffDistrict Court, D. South CarolinaHealth Care/Pharmaceutical Personal Injury Product Liabilitydefendant
1:26-cv-09028Individual plaintiffDistrict Court, N.D. IllinoisOther Personal Injurydefendant
8:26-cv-02086Individual plaintiffDistrict Court, M.D. FloridaPersonal Injury - Product Liabilitydefendant
1:26-cv-08580Individual plaintiffDistrict Court, N.D. IllinoisOther Personal Injurydefendant
8:26-cv-00247Warren v. Abbott Laboratories, Inc.District Court, D. NebraskaTort Product Liabilitydefendant
1:26-cv-00264Ghosh v. Abbott Laboratories, Inc.District Court, D. HawaiiFalse Claims Actdefendant
8:26-cv-02004Moss v. Abbott LaboratoriesDistrict Court, D. MarylandTort Product Liabilitydefendant
1:26-cv-05356Individual plaintiffDistrict Court, N.D. IllinoisPersonal Injury - Product Liabilitydefendant
1:26-cv-05322Individual plaintiffDistrict Court, N.D. IllinoisPersonal Injury - Product Liabilitydefendant
1:26-cv-04555Individual plaintiffDistrict Court, N.D. IllinoisPersonal Injury - Product Liabilitydefendant
2:26-cv-01555Individual plaintiffDistrict Court, E.D. CaliforniaPersonal Injury - Product Liabilitydefendant
1:26-cv-04172Individual plaintiffDistrict Court, N.D. IllinoisPersonal Injury - Product Liabilitydefendant
1:26-cv-03562Individual plaintiffDistrict Court, N.D. IllinoisPersonal Injury - Product Liabilitydefendant
1:26-cv-03404Individual plaintiffDistrict Court, N.D. IllinoisPersonal Injury - Product Liabilitydefendant
1:26-cv-02857Individual plaintiffDistrict Court, N.D. IllinoisPersonal Injury - Product Liabilitydefendant

The newest twenty are shown; the monthly table above counts all of them. A docket naming a company records an allegation or a proceeding, not a finding.

Dockets naming it as a defendant, by district

Districts with the most dockets naming Abbott Laboratories as a defendant, top 5 of 11, from CourtListener dockets
DistrictDockets as defendant
District Court, N.D. Illinois25
District Court, N.D. California2
District Court, D. Hawaii1
District Court, D. Maryland1
District Court, D. Nebraska1

Dockets naming it as a defendant, by case type

Nature of suit as coded on the civil cover sheet, labels from the JS 44 form
Case typeDockets as defendant
Personal Injury - Product Liability23
Health Care/Pharmaceutical Personal Injury Product Liability6
Tort Product Liability3
Other Personal Injury3
False Claims Act1

Timeline

  1. . Latest annual report: Form 10-K for the period ended 2025-12-31 (sec.gov)

Other public companies in the universe with the same reason for being tracked.

Sources

  1. data.sec.gov
  2. sec.gov
  3. sec.gov
  4. courtlistener.com
  5. courtlistener.com
  6. courtlistener.com
  7. courtlistener.com
  8. courtlistener.com
  9. courtlistener.com
  10. courtlistener.com
  11. courtlistener.com
  12. courtlistener.com
  13. courtlistener.com
  14. courtlistener.com
  15. courtlistener.com
  16. courtlistener.com
  17. courtlistener.com
  18. courtlistener.com
  19. courtlistener.com
  20. courtlistener.com
  21. courtlistener.com
  22. courtlistener.com
  23. courtlistener.com
  24. data.sec.gov
  25. sec.gov
  26. sec.gov
  27. sec.gov
  28. sec.gov
  29. sec.gov

How dockets are matched to companies and how every figure is sourced: Methodology.

Publication check: 31 sourced facts, floor 5
Why this page is published
Sourced facts31needs 5
Table rows10shown
Dated records with sources1shown
Primary identifiers (accessions, docket numbers)25needs 3
Primary-source links29shown
Internal links to published pages11shown
How the rankings are computed